Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of British Columbia, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of British Columbia, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of British Columbia, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
AXIM Biotech Enters into Agreement with University of British Columbia 12
Replicel Life Sciences Enters into Agreement with University of British Columbia 13
Ritter Pharma Enters into Agreement with University of British Columbia 14
TxCell Enters into Research Agreement with University of British Columbia 15
ProtoKinetix Enters into Research Agreement with University of British Columbia 16
Sirona Biochem Enters into Research Agreement with University of British Columbia 17
Qu Biologics Enters into Research Agreement with University of British Columbia 18
InMed Pharma Enters into Agreement with University of British Columbia 19
University of British Columbia Enters Into Agreement With Sichuan BoXin LaiTe Biotechnology And Heracles International Investment 20
Cangene Enters Into Research Agreement With University Of British Columbia 21
AlCana Extends Co-Development Agreement With UBC And Alnylam 22
CDRD Enters Into Co-Development Agreement With NGDI-UBC 23
Licensing Agreements 24
Roche Enters into Licensing Agreement with University of British Columbia and Vancouver Coastal Health Research Institute 24
BirchBioMed Enters into Licensing Agreement with University of British Columbia 25
Cyon Therapeutics Enters into Licensing Agreement with University of British Columbia 26
Cangene Enters Into Licensing Agreement With University of British Columbia 27
Advanced Inhalation Therapies Enters into Licensing Agreement with University of British Columbia 28
University of British Columbia – Key Competitors 29
University of British Columbia – Key Employees 30
University of British Columbia – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Government and Public Interest 33
Oct 03, 2017: Avon Foundation for Women (Canada) funds new breast cancer recovery trial in partnership with two Canadian universities 33
Sep 12, 2017: Alzheimer Society Research Program provides $3.4 million boost to dementia research 34
Jul 28, 2017: UBC researchers working to engineer ‘tunable’ insulin production 35
Nov 16, 2016: Marijuana could Help Treat Drug Addiction, Mental Health 36
Jul 15, 2016: Cell research could help with heart tissue transplants 37
Jun 16, 2016: BC Children’s Hospital researchers discover an early warning sign of transplant rejection 38
Jun 01, 2016: UBC-Vancouver Coastal Health scientists find genetic cause of multiple sclerosis 39
May 02, 2016: Childhood asthma research receives $2 million to investigate genetic and environmental factors 41
Apr 06, 2016: Results of World’s First Study on New Treatment for Heroin Addiction 42
Product News 43
Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 43
Sep 28, 2016: Antibiotics developed in 1960s show promise for TB therapy 44
Sep 07, 2016: UBC and Tilray Launch Canada’s First Clinical Trial to Study Medical Cannabis and PTSD 45
Clinical Trials 46
Oct 13, 2016: OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer 46
Oct 10, 2016: ESMO 2016: Custirsen Shows no Survival Benefits in Metastatic Prostate Cancer 47
Aug 16, 2016: OncoGenex Announced Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer 48
Other Significant Developments 49
Oct 26, 2017: The Human Vaccines Project Launches New Initiative To Accelerate Development Of Universally Effective Influenza Vaccines 49
Oct 17, 2017: Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery 50
Jun 24, 2016: Genome British Columbia Investing in Companies and Jobs Through e@UBC 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
University of British Columbia, Pharmaceuticals & Healthcare, Key Facts 2
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of British Columbia, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of British Columbia, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of British Columbia, Deals By Therapy Area, 2011 to YTD 2017 9
University of British Columbia, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AXIM Biotech Enters into Agreement with University of British Columbia 12
Replicel Life Sciences Enters into Agreement with University of British Columbia 13
Ritter Pharma Enters into Agreement with University of British Columbia 14
TxCell Enters into Research Agreement with University of British Columbia 15
ProtoKinetix Enters into Research Agreement with University of British Columbia 16
Sirona Biochem Enters into Research Agreement with University of British Columbia 17
Qu Biologics Enters into Research Agreement with University of British Columbia 18
InMed Pharma Enters into Agreement with University of British Columbia 19
University of British Columbia Enters Into Agreement With Sichuan BoXin LaiTe Biotechnology And Heracles International Investment 20
Cangene Enters Into Research Agreement With University Of British Columbia 21
AlCana Extends Co-Development Agreement With UBC And Alnylam 22
CDRD Enters Into Co-Development Agreement With NGDI-UBC 23
Roche Enters into Licensing Agreement with University of British Columbia and Vancouver Coastal Health Research Institute 24
BirchBioMed Enters into Licensing Agreement with University of British Columbia 25
Cyon Therapeutics Enters into Licensing Agreement with University of British Columbia 26
Cangene Enters Into Licensing Agreement With University of British Columbia 27
Advanced Inhalation Therapies Enters into Licensing Agreement with University of British Columbia 28
University of British Columbia, Key Competitors 29
University of British Columbia, Key Employees 30
University of British Columbia, Other Locations 31
University of British Columbia, Subsidiaries 31